{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:16:37Z","timestamp":1791918997367,"version":"4.3.4"},"reference-count":35,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,2,15]]},"abstract":"<jats:p>In the present study, we demonstrated that the antiapoptotic function of Bcl-2 in mast cells is significantly dependent on its association with the heat shock protein 90\u03b2 (Hsp90\u03b2). Dissociation of these 2 proteins inhibits the antiapoptotic activity of Bcl-2 by initiating the release of cytochrome c from mitochondria into cytosol and increasing the activity of caspase 3 and caspase 7, resulting in mast-cell apoptosis. The antiapoptotic activity of Bcl-2 was greatly affected by knocking-out specifically Hsp90\u03b2 using the RNA interference approach. Thus, for the first time, it has been shown that Hsp90\u03b2 might modulate the antiapoptotic activity of Bcl-2 at least in mast cells. These findings could have implications for a novel strategy of regulating apoptosis in patients with mastocytosis and other mast cell\u2013associated diseases.<\/jats:p>","DOI":"10.1182\/blood-2005-07-2648","type":"journal-article","created":{"date-parts":[[2005,9,16]],"date-time":"2005-09-16T00:44:52Z","timestamp":1126831492000},"page":"1413-1420","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":45,"title":["Antiapoptotic function of Bcl-2 in mast cells is dependent on its association with heat shock protein 90\u03b2"],"prefix":"10.1182","volume":"107","author":[{"given":"Cellina","family":"Cohen-Saidon","sequence":"first","affiliation":[{"name":"From the Department of Biochemistry, Hebrew University Hadassah Medical School, Jerusalem, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irit","family":"Carmi","sequence":"additional","affiliation":[{"name":"From the Department of Biochemistry, Hebrew University Hadassah Medical School, Jerusalem, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avishai","family":"Keren","sequence":"additional","affiliation":[{"name":"From the Department of Biochemistry, Hebrew University Hadassah Medical School, Jerusalem, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehud","family":"Razin","sequence":"additional","affiliation":[{"name":"From the Department of Biochemistry, Hebrew University Hadassah Medical School, Jerusalem, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111900034464500_REF1","doi-asserted-by":"crossref","unstructured":"Mekori YA, Metcalfe DD. Mast cells in innate immunity. Immunol Rev. 2000;173: 131-140.","DOI":"10.1034\/j.1600-065X.2000.917305.x"},{"key":"2019111900034464500_REF2","doi-asserted-by":"crossref","unstructured":"Piliponsky AM, Levi-Schaffer F. Regulation of apoptosis in mast cells. Apoptosis. 2000;5: 435-441.","DOI":"10.1023\/A:1009680500988"},{"key":"2019111900034464500_REF3","doi-asserted-by":"crossref","unstructured":"Mekori YA, Gilfillan AM, Akin C, Hartmann K, Metcalfe DD. Human mast cell apoptosis is regulated through Bcl-2 and Bcl-XL. J Clin Immunol. 2001; 21: 171-174.","DOI":"10.1023\/A:1011083031272"},{"key":"2019111900034464500_REF4","doi-asserted-by":"crossref","unstructured":"Cohen-Saidon C, Nechushtan H, Kahlon S, Livni N, Nissim A, Razin E. A novel strategy using single-chain antibody to show the importance of Bcl-2 in mast cell survival. Blood. 2003;102: 2506-2512.","DOI":"10.1182\/blood-2002-12-3921"},{"key":"2019111900034464500_REF5","doi-asserted-by":"crossref","unstructured":"Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell. 2004;116: 205-219.","DOI":"10.1016\/S0092-8674(04)00046-7"},{"key":"2019111900034464500_REF6","unstructured":"Korsmeyer SJ. BCL-2 gene family and the regulation of programmed cell death. Cancer Res. 1999;59: 1693s-1700s."},{"key":"2019111900034464500_REF7","doi-asserted-by":"crossref","unstructured":"Cory S, Huang DC, Adams JM. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene. 2003;22: 8590-8607.","DOI":"10.1038\/sj.onc.1207102"},{"key":"2019111900034464500_REF8","doi-asserted-by":"crossref","unstructured":"Droin NM, Green DR. Role of Bcl-2 family members in immunity and disease. Biochim Biophys Acta. 2004;1644: 179-188.","DOI":"10.1016\/j.bbamcr.2003.10.011"},{"key":"2019111900034464500_REF9","doi-asserted-by":"crossref","unstructured":"Donovan M, Cotter TG. Control of mitochondrial integrity by Bcl-2 family members and caspase-independent cell death. Biochim Biophys Acta. 2004;1644: 133-147.","DOI":"10.1016\/j.bbamcr.2003.08.011"},{"key":"2019111900034464500_REF10","doi-asserted-by":"crossref","unstructured":"Reed JC. Mechanisms of apoptosis. Am J Pathol. 2000;157: 1415-1430.","DOI":"10.1016\/S0002-9440(10)64779-7"},{"key":"2019111900034464500_REF11","doi-asserted-by":"crossref","unstructured":"Lin B, Kolluri SK, Lin F, et al. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77\/TR3. Cell. 2004;116: 527-540.","DOI":"10.1016\/S0092-8674(04)00162-X"},{"key":"2019111900034464500_REF12","doi-asserted-by":"crossref","unstructured":"Park HS, Lee JS, Huh SH, Seo JS, Choi EJ. Hsp72 functions as a natural inhibitory protein of c-Jun N-terminal kinase. EMBO J. 2001;20: 446-456.","DOI":"10.1093\/emboj\/20.3.446"},{"key":"2019111900034464500_REF13","unstructured":"Takayama S, Krajewski S, Krajewska M, et al. Expression and location of Hsp70\/Hsc-binding anti\u2013apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines. Cancer Res. 1998;58: 3116-3131."},{"key":"2019111900034464500_REF14","doi-asserted-by":"crossref","unstructured":"Chant ID, Rose PE, Morris AG. Susceptibility of AML cells to in vitro apoptosis correlates with heat shock protein 70 (hsp 70) expression. Br J Haematol. 1996;93: 898-902.","DOI":"10.1046\/j.1365-2141.1996.d01-1737.x"},{"key":"2019111900034464500_REF15","doi-asserted-by":"crossref","unstructured":"Razin E, Ihle JN, Seldin D, et al. Interleukin 3: a differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan. J Immunol. 1984;132: 1479-1486.","DOI":"10.4049\/jimmunol.132.3.1479"},{"key":"2019111900034464500_REF16","doi-asserted-by":"crossref","unstructured":"Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science. 2002;296: 550-553.","DOI":"10.1126\/science.1068999"},{"key":"2019111900034464500_REF17","doi-asserted-by":"crossref","unstructured":"Gropp M, Itsykson P, Singer O, et al. Stable genetic modification of human embryonic stem cells by lentiviral vectors. Mol Ther. 2003;7: 281-287.","DOI":"10.1016\/S1525-0016(02)00047-3"},{"key":"2019111900034464500_REF18","doi-asserted-by":"crossref","unstructured":"Scheibel T, Siegmund HI, Jaenicke R, Ganz P, Lilie H, Buchner J. The charged region of Hsp90 modulates the function of the N-terminal domain. Proc Natl Acad Sci U S A. 1999;96: 1297-1302.","DOI":"10.1073\/pnas.96.4.1297"},{"key":"2019111900034464500_REF19","doi-asserted-by":"crossref","unstructured":"Grenert JP, Johnson BD, Toft DO. The importance of ATP binding and hydrolysis by hsp90 in formation and function of protein heterocomplexes. J Biol Chem. 1999;274: 17525-17533.","DOI":"10.1074\/jbc.274.25.17525"},{"key":"2019111900034464500_REF20","doi-asserted-by":"crossref","unstructured":"Roe SM, Prodromou C, O'Brien R, Ladbury JE, Piper PW, Pearl LH. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin. J Med Chem. 1999;42: 260-266.","DOI":"10.1021\/jm980403y"},{"key":"2019111900034464500_REF21","doi-asserted-by":"crossref","unstructured":"Fortugno P, Beltrami E, Plescia J, et al. Regulation of survivin function by Hsp90. Proc Natl Acad Sci U S A. 2003;100: 13791-13796.","DOI":"10.1073\/pnas.2434345100"},{"key":"2019111900034464500_REF22","doi-asserted-by":"crossref","unstructured":"Dias S, Shmelkov SV, Lam G, Rafii S. VEGF(165) promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition. Blood. 2002;99: 2532-2540.","DOI":"10.1182\/blood.V99.7.2532"},{"key":"2019111900034464500_REF23","doi-asserted-by":"crossref","unstructured":"Passarino G, Cavalleri GL, Stecconi R, et al. Molecular variation of human HSP90alpha and HSP90beta genes in Caucasians. Hum Mutat. 2003;21: 554-555.","DOI":"10.1002\/humu.9141"},{"key":"2019111900034464500_REF24","doi-asserted-by":"crossref","unstructured":"Tsujimura T, Furitsu T, Morimoto M, et al. Substitution of an aspartic acid results in constitutive activation of c-kit receptor tyrosine kinase in a rat tumor mast cell line RBL-2H3. Int Arch Allergy Immunol. 1995;106: 377-385.","DOI":"10.1159\/000236870"},{"key":"2019111900034464500_REF25","doi-asserted-by":"crossref","unstructured":"Mollinedo F, Gajate C. Microtubules, microtubule-interfering agents and apoptosis. Apoptosis. 2003;8: 413-450.","DOI":"10.1023\/A:1025513106330"},{"key":"2019111900034464500_REF26","doi-asserted-by":"crossref","unstructured":"Blagosklonny MV, Fojo T. Molecular effects of paclitaxel: myths and reality (a critical review). Int J Cancer. 1999;83: 151-156.","DOI":"10.1002\/(SICI)1097-0215(19991008)83:2<151::AID-IJC1>3.0.CO;2-5"},{"key":"2019111900034464500_REF27","doi-asserted-by":"crossref","unstructured":"Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 1999;13: 1899-1911.","DOI":"10.1101\/gad.13.15.1899"},{"key":"2019111900034464500_REF28","doi-asserted-by":"crossref","unstructured":"Fontana J, Fulton D, Chen Y, et al. Domain mapping studies reveal that the M domain of hsp90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase and NO release. Circ Res. 2002; 90: 866-873.","DOI":"10.1161\/01.RES.0000016837.26733.BE"},{"key":"2019111900034464500_REF29","doi-asserted-by":"crossref","unstructured":"Fumo G, Akin C, Metcalfe DD, Neckers L. 17-Allylamino-17-demethoxygeldanamycin (17-AAG) is effective in down-regulating mutated, constitutively activated KIT protein in human mast cells. Blood. 2004;103: 1078-1084.","DOI":"10.1182\/blood-2003-07-2477"},{"key":"2019111900034464500_REF30","doi-asserted-by":"crossref","unstructured":"Workman P. Altered states: selectively drugging the Hsp90 cancer chaperone. Trends Mol Med. 2004;10: 47-51.","DOI":"10.1016\/j.molmed.2003.12.005"},{"key":"2019111900034464500_REF31","doi-asserted-by":"crossref","unstructured":"Kamal A, Thao L, Sensintaffar J, et al. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature. 2003;425: 407-410.","DOI":"10.1038\/nature01913"},{"key":"2019111900034464500_REF32","doi-asserted-by":"crossref","unstructured":"Pratt WB, Toft DO. Regulation of signaling protein function and trafficking by the hsp90\/hsp70-based chaperone machinery. Exp Biol Med (May-wood). 2003;228: 111-133.","DOI":"10.1177\/153537020322800201"},{"key":"2019111900034464500_REF33","doi-asserted-by":"crossref","unstructured":"Cissel DS, Beaven MA. Disruption of Raf-1\/heat shock protein 90 complex and Raf signaling by dexamethasone in mast cells. J Biol Chem. 2000; 275: 7066-7070.","DOI":"10.1074\/jbc.275.10.7066"},{"key":"2019111900034464500_REF34","doi-asserted-by":"crossref","unstructured":"Piatelli MJ, Doughty C, Chiles TC. Requirement for an hsp90 chaperone-dependent MEK1\/2-ERK pathway for B cell antigen receptor-induced cyclin D2 expression in mature B lymphocytes. J Biol Chem. 2002;277: 12144-12150.","DOI":"10.1074\/jbc.M200102200"},{"key":"2019111900034464500_REF35","doi-asserted-by":"crossref","unstructured":"Song J, Takeda M, Morimoto RI. Bag1-Hsp70 mediates a physiological stress signalling pathway that regulates Raf-1\/ERK and cell growth. Nat Cell Biol. 2001;3: 276-282.","DOI":"10.1038\/35060068"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/4\/1413\/468651\/zh800406001413.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/4\/1413\/468651\/zh800406001413.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T15:01:06Z","timestamp":1683212466000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/107\/4\/1413\/133672\/Antiapoptotic-function-of-Bcl2-in-mast-cells-is"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,15]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,2,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-07-2648","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2,15]]}}}